teveten plus 600/12.5 eprosartan 600mg/hydrochlorothiazide 12.5mg tablet blister pack
viatris pty ltd - hydrochlorothiazide, quantity: 12.5 mg; eprosartan mesilate, quantity: 735.8 mg (equivalent: eprosartan, qty 600 mg) - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; lactose monohydrate; magnesium stearate; pregelatinised maize starch; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; iron oxide black - teveten plus is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.
teveten eprosartan 600mg (as mesilate) tablet blister pack
viatris pty ltd - eprosartan mesilate, quantity: 735.8 mg (equivalent: eprosartan, qty 600 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; crospovidone; magnesium stearate; pregelatinised maize starch; hypromellose; macrogol 400; polysorbate 80; titanium dioxide - teveten is indicated for the treatment of essential hypertension.
teveten eprosartan 400mg (as mesilate) tablet blister pack
viatris pty ltd - eprosartan mesilate, quantity: 400 mg (equivalent: eprosartan mesilate, qty 400 mg) - tablet, film coated - excipient ingredients: magnesium stearate; pregelatinised maize starch; microcrystalline cellulose; lactose monohydrate; croscarmellose sodium; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; iron oxide red; macrogol 400 - teveten is indicated for the treatment of essential hypertension.
teveten hct- eprosartan mesylate and hydrochlorothiazide tablet
physicians total care, inc. - eprosartan mesylate (unii: 8n2l1nx8s3) (eprosartan - unii:2kh13z0s0y), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - eprosartan 600 mg - teveten® hct is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensives such as calcium channel blockers. this fixed dose combination is not indicated for initial therapy (see dosage and administration ). teveten® hct is contraindicated in patients who are hypersensitive to this product or any of its components. because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs.
tevetens 600 mg comprimidos recubiertos con pelicula
mylan ire healthcare limited - eprosartan - comprimido recubierto con pelÍcula - 600 mg - eprosartan 600 mg - eprosartán
tevetens plus 600 mg/12,5 mg, comprimidos recubiertos con pelicula
mylan ire healthcare limited - eprosartan mesilato dihidrato; hidroclorotiazida - comprimido recubierto con pelÍcula - 600 mg/12,5 mg - eprosartan mesilato dihidrato 600 mg; hidroclorotiazida 12,5 mg - eprosartan y diuréticos
coteveten 600 mg/ 12,5 mg filmsko obložene tablete
mylan healtcare gmbh - eprosartan; hidroklorotiazid - filmsko obložena tableta - eprosartan 600 mg / 1 tableta hidroklorotiazid12,5 mg / 1 tableta; hidroklorotiazid 12,5 mg / 1 tableta - eprosartan in diuretiki
coteveten 600 mg/ 12,5 mg filmsko obložene tablete
mylan healtcare gmbh - eprosartan; hidroklorotiazid - filmsko obložena tableta - eprosartan 600 mg / 1 tableta hidroklorotiazid12,5 mg / 1 tableta; hidroklorotiazid 12,5 mg / 1 tableta - eprosartan in diuretiki
coteveten 600 mg/ 12,5 mg filmsko obložene tablete
mylan healtcare gmbh - eprosartan, hidroklorotiazid - filmsko obložena tableta - eprosartan 600 mg / 1 tableta; hidroklorotiazid 12,5 mg / 1 tableta - eprosartan in diuretiki
teveten plus 600 mg - 12.5 mg filmomh. tabl.
viatris healthcare sa-nv - eprosartanmesilaat 735,8 mg - eq. eprosartan 600 mg; hydrochloorthiazide 12,5 mg - filmomhulde tablet - 600 mg - 12,5 mg - eprosartanmesilaat 735.8 mg; hydrochloorthiazide 12.5 mg - eprosartan and diuretics